Jan Garfinkle is the founder and managing director of Arboretum Ventures. See sector focus and contact routes.
Jan Garfinkle is the founder and managing director of Arboretum Ventures, a healthcare-focused venture capital firm in Ann Arbor, Michigan, where she has led the company since establishing it in 2002. Her investment thesis targets promising medical device and diagnostic technologies that enable healthcare system savings, focusing on early-stage opportunities in medical devices, diagnostics, life science tools, and tech-enabled care delivery. Garfinkle typically leads investments with check sizes in the $10 million to $15 million range, often acting as the lead investor rather than a follower. Notable portfolio companies she has led include HandyLab (acquired by Becton Dickinson), CardioMEMS, Uptake Medical, BAROnova, Vasonova, and Cerêve. She serves on the boards of several portfolio companies including Cardiac Dimensions, Cereve, NeuMoDx, NxThera, and Strata Oncology, and has held leadership roles at the National Venture Capital Association. Garfinkle distinguishes herself as a rare woman who founded and runs a venture capital firm, leveraging her bioengineering background from UC Berkeley and MBA from Wharton to select and nurture healthcare companies.
This profile is part of the StartupFundraising investor database: focus, portfolio history, disclosed location and contact routes, refreshed as new filings and rounds are ingested. Founders use it to check fit before reaching out and to find investors in Ann Arbor.
Investors like Jan Garfinkle · Full investor directory · Investor access · Company funding database